Modified .beta..sub.2 -microglobulin

Chemistry: analytical and immunological testing – Involving production or treatment of antibody – Monoclonal antibody

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

436518, 436804, 435 71, 435 75, 435 792, 435 793, 424 858, 5303879, 53038885, 5303911, 5303913, 530403, G01N 33577, G01N 3353, C07K 1528

Patent

active

051751135

ABSTRACT:
Substantially pure modified .beta..sub.2 -microglobulin (m.beta..sub.2 m) of the formula I ##STR1## wherein R.sub.1 is 24-amino acid residue, with the sequence Ile-Gln-Arg-Thr-Pro-Lys-Ile-Gln-Val-Tyr-Ser-Arg-His-Pro-Ala-Glu-Asn-Gly-Ly s-Ser-Asn-Phe-Leu-Asn, R.sub.2 is a 30-amino acid residue with the sequence Tyr-Val-Ser-Gly-Phe-His-Pro-Ser-Asp-Ile-Glu-Val-Asp-Leu-Leu-Lys-Asn-Gly-Gl u-Arg-Ile-Gly-Lys-Val-Glu-His-Ser-Asp-Leu-Ser, R.sub.3 is a 20-amino acid residue with the sequence Trp-Ser-Phe-Tyr-Leu-Leu-Tyr-Tyr-Glu-Phe-Thr-Pro-Thr-Glu-Lys-Asp-Glu-Tyr-Al a, R.sub.4 is a 19-amino acid residue with the sequence Arg-Val-Asn-His-Val-Thr-Leu-Ser-Gln-Pro-Lys-Ile-Val-Lys-Trp-Asp-Arg-Asp-Me t, X is Phe, Phe-Ser, or Phe-Ser-Lys, and Y is Asp, Lys-Asp, or Ser-Lys-Asp is disclosed. The presence of the protein in body fluids is a diagnostic and/or prognostic marker for the development of a variety of disorders such as different types of cancer and diseases involving the immune system. Also disclosed are specific anti-m.beta..sub.2 m antibodies used for the detection and quantification of m.beta..sub.2 m.

REFERENCES:
patent: 4376110 (1983-03-01), David et al.
Hopp et al, "Prediction of protein antigenic determinants from amino acid sequences" Proc. Natl. Acad. Sci. USA, 78(6):3824-3828 (Jun. 1981).
Hopp et al, "A Computer Program for Predicting Protein Antigenic Determinants" Mol. Immunol. 20(4):483-489 (1983).
Taggart et al, "Stable Antibody-Producing Murine Hybridomas", Science 219:1228-30 (Mar. 11, 1983).
Wide "Chapter 13 Noncompetitive Versus Competitive Binding Assays" in Principles of Competitive Protein-Binding Assays, 2nd Ed. pp. 243-254 (1983).
ATCC (American Type Culture Collection) Catalogue of Cell Lines and Hybridomas Fifth Edition, pp. 212, 217 and 222 (1985).
The Calbiochem Biochemical and Immunochemical Catalog, pp. 204-205 (1985).
Cunningham, et al., Biochem. 12(24):4811-4821 (1973).
Suggs et al., Proc. Natl. Acad. Sci. USA 78(11):6613-6617 (1981).
Plesner et al., Scand. J. Immunol. 11:341-351 (1980).
Bhalla et al., Clinical Chemistry 31(8):1411 (1985).
Peterson et al., Proc. Nat. Acad. Sci. USA 71(1):35-39 (1974).
Terhorst et al., Cell (23):771-780 (1981).
Nissen, et al. Clinica Chimica Acta 141:41-50 (1984).
Plesner et al., Scand J. Immunol. 9:247-254 (1979).
Plesner, T. Allergy 35:627-637 (1980).
Plesner, et al., Scand. J. Clin. Lab. Invest. 35:729-735 (1975).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Modified .beta..sub.2 -microglobulin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified .beta..sub.2 -microglobulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified .beta..sub.2 -microglobulin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1886751

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.